How Doctors Today Are Screening Smarter for Prostate Cancer

Within a few years of using prostate-specific antigen (PSA) tests, we saw an amazing shift: By the mid-1990s, most men newly diagnosed with prostate cancer were curable. Since then, studies have shown that while PSA screening reduces a man’s likelihood of dying from prostate cancer, it does not reduce overall mortality. The problem has been with how we use PSA tests.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Advertising Policy